A phase 1/2 of a combination of Cetuximab and Taxane for “triple negative” breast cancer patients
| Autor: | Nechushtan, Hovav, Vainer, Gilad, Stainberg, Hana, Salmon, Asher Y., Hamburger, Tamar, Peretz, Tamar |
|---|---|
| Zdroj: | In The Breast August 2014 23(4):435-438 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect